RedHill Biopharma Initiates Global Phase 2/3 Study for COVID-19

NEXT STORY
Lexicon Pharmaceuticals Enters Into Agreement With TerSera Therapeutics for the Sale of XERMELO
PREV STORY
Airway Management Devices Global Market Report 2020-30: Covid 19 Implications and Growth
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Krystal Biotech Announces Completion of the GEM-3 Pivotal Phase 3 Study Evaluating B-VEC for the Treatment of Dystrophic Epidermolysis Bullosa

author_avatar
NASDAQ Market News

Rexahn Pharmaceuticals Announces Poster Presentation of RX-3117 Data in Metastatic Pancreatic Patients at the American Society of Clinical Oncology Gastrointestinal Cancers (ASCO GI) 2018 Annual Meeting

Encouraging Progression Free Survival and Evidence of Tumor Shrinkage Observed in Patients with Metastatic ...

author_avatar
NASDAQ Market News

Tiziana Life Sciences Announces Initiation of Clinical Trial in a Secondary Progressive Multiple Sclerosis (SPMS) Patient with Nasal Administration of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, Under an Individual Patient Expanded Access Program

author_avatar
NASDAQ Market News